We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
(-6.3%)
Cap. Flow
+$5.08B
Cap. Flow
% of AUM
14.42%
Top 10 Holdings %
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$410M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Altria Group
MO
|
+$312M |
| 4 |
Meta Platforms (Facebook)
META
|
+$295M |
| 5 |
Intel
INTC
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$407M |
| 2 |
AbbVie
ABBV
|
+$283M |
| 3 |
S&P Global
SPGI
|
+$251M |
| 4 |
Amazon
AMZN
|
+$221M |
| 5 |
Eli Lilly
LLY
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Healthcare | 18.6% |
| 3 | Financials | 10.47% |
| 4 | Industrials | 10.2% |
| 5 | Consumer Discretionary | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Myriad Genetics
MYGN
$502M
| $763K | ﹤0.01% |
42,000
-15,700
| -27% | -$326K |
|
1727
STMicroelectronics
STM
$44.7B
| $758K | ﹤0.01% |
24,100
-18,300
| -43% | -$682K |
|
1728
TETRA Technologies
TTI
$1.07B
| $757K | ﹤0.01% |
186,356
+11,656
| +7% | +$51.3K |
|
1729
Brookfield Infrastructure Partners
BIP
$19.3B
| $755K | ﹤0.01% |
19,750
-12,950
| -40% | -$532K |
|
1730
Helios Technologies
HLIO
$2.56B
| $755K | ﹤0.01% |
+11,400
| New | +$791K |
|
1731
Teekay
TK
$981M
| $752K | ﹤0.01% |
261,100
+114,000
| +77% | +$373K |
|
|
ATSG
1732
DELISTED
Air Transport Services Group
ATSG
| $750K | ﹤0.01% |
26,100
+15,900
| +156% | +$484K |
|
1733
DTE Energy
DTE
$30.4B
| $748K | ﹤0.01% |
+5,900
| New | +$769K |
|
1734
Tejon Ranch
TRC
$467M
| $747K | ﹤0.01% |
48,100
-3,600
| -7% | -$62.1K |
|
1735
Allegiant Air
ALGT
$2.73B
| $746K | ﹤0.01% |
6,600
+3,700
| +128% | +$533K |
|
|
CATC
1736
DELISTED
CAMBRIDGE BANCORP
CATC
| $744K | ﹤0.01% |
9,000
-2,900
| -24% | -$239K |
|
1737
Nature's Sunshine
NATR
$365M
| $742K | ﹤0.01% |
69,500
-18,900
| -21% | -$263K |
|
1738
Exponent
EXPO
$3.15B
| $741K | ﹤0.01% |
8,100
-4,000
| -33% | -$377K |
|
1739
Southern First Bancshares
SFST
$592M
| $741K | ﹤0.01% |
17,000
-300
| -2% | -$13.6K |
|
1740
Century Casinos
CNTY
$32.6M
| $740K | ﹤0.01% |
102,800
-35,900
| -26% | -$335K |
|
1741
MiMedx Group
MDXG
$649M
| $738K | ﹤0.01% |
212,700
-12,500
| -6% | -$48.9K |
|
1742
Preformed Line Products
PLPC
$1.45B
| $738K | ﹤0.01% |
12,000
+7,200
| +150% | +$445K |
|
|
ILLM
1743
DELISTED
illumin Holdings Inc. Common Shares
ILLM
| $738K | ﹤0.01% |
319,600
-140,300
| -31% | -$378K |
|
1744
Cardiff Oncology
CRDF
$63.6M
| $737K | ﹤0.01% |
334,800
-179,300
| -35% | -$300K |
|
|
PETQ
1745
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $737K | ﹤0.01% |
43,900
-10,900
| -20% | -$200K |
|
1746
Sabra Healthcare REIT
SBRA
$5.61B
| $736K | ﹤0.01% |
+52,700
| New | +$705K |
|
1747
Coherus Oncology
CHRS
$222M
| $734K | ﹤0.01% |
101,400
+24,800
| +32% | +$216K |
|
1748
Dick's Sporting Goods
DKS
$18.9B
| $731K | ﹤0.01% |
9,700
-62,500
| -87% | -$5.56M |
|
1749
Alta Equipment Group
ALTG
$207M
| $727K | ﹤0.01% |
81,100
+1,500
| +2% | +$16.4K |
|
|
ETNB
1750
DELISTED
89bio
ETNB
| $726K | ﹤0.01% |
225,400
+52,000
| +30% | +$157K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.
- Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
- Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
- Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
- Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
- Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
- Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.
Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.